Infliximab (Remicade) in the treatment of psoriatic arthritis.
about
Patented small molecules against psoriasis.Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.Infliximab for the treatment of refractory scleritis.Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats.
P2860
Infliximab (Remicade) in the treatment of psoriatic arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infliximab (Remicade) in the treatment of psoriatic arthritis.
@en
Infliximab
@nl
type
label
Infliximab (Remicade) in the treatment of psoriatic arthritis.
@en
Infliximab
@nl
prefLabel
Infliximab (Remicade) in the treatment of psoriatic arthritis.
@en
Infliximab
@nl
P2860
P1476
Infliximab (Remicade) in the treatment of psoriatic arthritis.
@en
P2093
Philip Mease
P2860
P304
P356
10.2147/TCRM.2006.2.4.389
P577
2006-12-01T00:00:00Z